- Home
- DGLY vs CYCN Comparison
DGLY vs CYCN Comparison
Compare DGLY & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGLY
- CYCN
- Stock Information
- Founded
- DGLY 2004
- CYCN 2018
- Country
- DGLY United States
- CYCN United States
- Employees
- DGLY N/A
- CYCN N/A
- Industry
- DGLY Radio And Television Broadcasting And Communications Equipment
- CYCN Biotechnology: Pharmaceutical Preparations
- Sector
- DGLY Technology
- CYCN Health Care
- Exchange
- DGLY Nasdaq
- CYCN Nasdaq
- Market Cap
- DGLY 6.3M
- CYCN 7.5M
- IPO Year
- DGLY N/A
- CYCN N/A
- Fundamental
- Price
- DGLY $0.03
- CYCN $2.61
- Analyst Decision
- DGLY
- CYCN
- Analyst Count
- DGLY 0
- CYCN 0
- Target Price
- DGLY N/A
- CYCN N/A
- AVG Volume (30 Days)
- DGLY 48.3M
- CYCN 31.9K
- Earning Date
- DGLY 05-16-2025
- CYCN 03-04-2025
- Dividend Yield
- DGLY N/A
- CYCN N/A
- EPS Growth
- DGLY N/A
- CYCN N/A
- EPS
- DGLY N/A
- CYCN N/A
- Revenue
- DGLY $21,131,122.00
- CYCN $2,000,000.00
- Revenue This Year
- DGLY $22.14
- CYCN N/A
- Revenue Next Year
- DGLY N/A
- CYCN N/A
- P/E Ratio
- DGLY N/A
- CYCN N/A
- Revenue Growth
- DGLY N/A
- CYCN N/A
- 52 Week Low
- DGLY $0.02
- CYCN $1.27
- 52 Week High
- DGLY $3.29
- CYCN $9.47
- Technical
- Relative Strength Index (RSI)
- DGLY 30.57
- CYCN 47.14
- Support Level
- DGLY $0.03
- CYCN $2.44
- Resistance Level
- DGLY $0.10
- CYCN $2.85
- Average True Range (ATR)
- DGLY 0.01
- CYCN 0.20
- MACD
- DGLY 0.00
- CYCN 0.02
- Stochastic Oscillator
- DGLY 20.73
- CYCN 35.68
About DGLY Digital Ally Inc.
Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.